000 04908nam a2200421 i 4500
999 _c361070
_d361070
001 361070
003 ES-MaUEC
005 20230102121318.0
006 a||||fo|||| 00| 0
007 cr nn nnnaamaa
008 210723s2021 sz a s |||| 0|eng d
020 _a9783030674595
024 7 _a10.1007/978-3-030-67459-5
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
_dES-MaUEC
050 4 _aRM267
_b2021 EB
100 1 _aFinberg, Robert W.
_eautor
_4aut
_4http://id.loc.gov/vocabulary/relators/aut
_9681506
245 1 0 _aClinical Use of Anti-infective Agents .
_bA Guide on How to Prescribe Drugs Used to Treat Infections
_cby Robert W. Finberg, Roy Guharoy
250 _aSecond edition 2021
264 1 _aCham
_bSpringer International Publishing
_c2021
264 4 _c2021
300 _a1 recurso en línea (XIV, 300 páginas)
_b82 ilustraciones
336 _2rdacontent
_aTexto
_btxt
337 _2rdamedia
_aelectrónico
_bc
338 _2rdacarrier
_arecurso electrónico
_bcr
347 _aArchivo de texto
_bPDF
490 0 _aBiomedical and Life Sciences (SpringerNature-11642)
490 0 _aBiomedical and Life Sciences (R0) (SpringerNature-43708)
505 0 _a1. Introduction and history -- 2. Basic principles of drug delivery and dosing -- 3. Sulfonamides -- 4. Penicillins -- 5. Cephalosporins -- 6. Monobactams: Aztreonam -- 7. Carbapenems -- 8. Glycopeptides and other agents used to treat gram-positive cocci -- 9. Vancomycin: New Area-under-the-curve-based therapeutic monitoring -- 10. Aminoglycosides -- 11. Macrolides -- 12. Metronidazole and clindamycin -- 13. Quinolones -- 14. Tetracyclines -- 15. Pleuromutilin -- 16. Antimicrobial stewardship: evolution into the 21st century -- 17. Clinical approach to the treatment of infectious diseases -- 18. Understanding drug allergies and drug toxicities -- 19. Antibiotic-associated diarrhea -- 20. Principles of antibiotic resistance -- 21. Clinical approach to treatment of bacterial infections -- 22. Clinical approach to treatment of mycobacterial infections -- 23. Clinical approach to treatment of fungal infections -- 24. Clinical approach to treatment of viral infections -- 25. Sample cases and analyses of the use of anti-infective agents: Cases 1-15 -- Appx A. Common infectious diseases and empiric antibiotic recommendations for adult ed and inpatients at UMass Memorial Medical Center -- Appx B. Bioavailability of anti-infective agents -- Appx C. Dosage and intervals for administration of IV antimicrobials -- Appx D. Dosage and intervals for administration of oral antimicrobials -- Appx E. Important interactions with commonly-used anti-infectives -- Appx F. Oral agents that may have interactions with food -- Appx G. Drug interactions with anti-retroviral agents -- Appx H. Dosage in obesity -- Appx I. Recommendations for management of Asymptomatic Bacteriuria (ASB): 2019 update -- Appx J. Guidelines for treatment of C. difficile -- Appx K. Antimicrobial prophylaxis for adult patients with cancer-related immunosuppression -- Appx L. Guidelines for treatment of adults with community-acquired pneumonia -- Appx M. Guidelines for management of adults with hospital-acquired and ventilator-associated pneumonia -- Appx N. Guidelines for antimicrobial prophylaxis for surgery -- Appx O. Guidelines for treatment and chemoprophylaxis of influenza -- Appx P. Antimicrobial dosing in adult patients on extracorporeal membrane oxygenation (EXMO) -- Appx Q. Antimicrobial dosing in neonates.
520 3 _aThis second edition of Clinical Use of Anti-Infective Agents provides a comprehensive overview of current approaches to using drugs to treat infections, including historical perspectives, definitions, and discussion of pharmacokinetics and pharmacodynamics and their uses. It includes a detailed explanation of different classes of drugs, outlining their spectrum, pharmacokinetics, side effects, and dosing in clinical settings. This book has been designed as a reference tool for pharmacists, clinicians, nurse practitioners, and clinical microbiologists, as well as a teaching vehicle for students studying infection and patient treatment. Each section includes references allowing for in-depth study of specific agents, Q&As, and illustrative case studies accompanied by commentary on how to approach patients and organisms, optimal methods of making a diagnosis, and prescribing treatment.
988 _aSpringer_BiomedLife_2021
650 7 _2embne
_9138527
_aAntibióticos
700 1 _aGuharoy, Roy
_eautor
_4aut
_4http://id.loc.gov/vocabulary/relators/aut
_9681507
776 0 8 _iPrinted edition:
_z9783030674588
776 0 8 _iPrinted edition:
_z9783030674601
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-67459-5
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942 _2lcc
_cLE
998 _b02/2022
_dz
_ek
_zSI